Theoretical and practical study of the cefoxitin‐Escherichia coli PBP5 complex interaction by molecular dynamics to obtain computational prototype of antimicrobial susceptibility to Gram negative bacteria-Reference-Cited by-同舟云学术

Theoretical and practical study of the cefoxitin‐Escherichia coli PBP5 complex interaction by molecular dynamics to obtain computational prototype of antimicrobial susceptibility to Gram negative bacteria

Published:2020-09-09 Issue:4 Volume:96 Page:1095-1102
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Silva Thaís Boulhosa Barros da¹,Monteiro Marta Chagas¹,Borges Rosivaldo dos Santos²,Barros Tainá Guimarães³,Carneiro Agnaldo da Silva³,Barros Carlos Augusto Lima³

Affiliation:

1. Programa de Pós‐graduação em Ciências Farmacêuticas Instituto de Ciências da Saúde Universidade Federal do Pará Belém Brasil

2. Núcleo de Estudos e Seleção de Moléculas Bioativas Instituto de Ciências da Saúde Universidade Federal do Pará Belém Brasil

3. Laboratório de Bioquímica Molecular e Quântica Instituto de Ciências da Saúde Universidade Federal do Pará Belém Brasil

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cbdd.13358

Reference42 articles.

1. Penicillin‐Binding Protein‐Mediated Resistance in Pneumococci and Staphylococci

2. Estimation of the State of the Bacterial Cell Wall by Fluorescent In Situ Hybridization

3. Branching of Escherichia coli Cells Arises from Multiple Sites of Inert Peptidoglycan

4. A functional classification scheme for beta-lactamases and its correlation with molecular structure

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A series of zinc(II) and copper(II) complexes derived from 5-bromo-2((2-(dimethylamino)ethylimino)methyl)phenol: syntheses, characterization, crystal structures and antimicrobial activity;Journal of Coordination Chemistry;2021-06-18

2. Challenge in the Discovery of New Drugs: Antimicrobial Peptides against WHO-List of Critical and High-Priority Bacteria;Pharmaceutics;2021-05-21